Child Dies from Rare Measles Complication Years After Infection

A tragic case in Los Angeles highlights the dangers of measles and its severe complication, SSPE, especially in unvaccinated infants. Vaccination is crucial to prevent such outcomes.
A young child in Los Angeles County has tragically succumbed to a rare and severe complication of measles, despite having contracted the virus in infancy. According to health officials, the child was too young to be vaccinated at the time of infection, which occurred years ago. The cause of death was identified as subacute sclerosing panencephalitis (SSPE), an incurable neurological disorder that results in progressive brain damage and is nearly always fatal. While SSPE develops in approximately 1 in 10,000 measles cases, the risk significantly increases among infants infected at a very young age, with about 1 in 600 infants affected. This case underscores the ongoing dangers of measles, emphasizing the critical importance of vaccination, especially for vulnerable populations. Dr. Muntu Davis, the Los Angeles County health officer, highlighted that infants depend on community immunity to stay protected from such dangerous outcomes. The current year marks the most severe measles outbreak in over three decades in the United States, with the CDC reporting 1,454 confirmed cases and three fatalities as of recent data. Vaccination remains the most effective way to prevent measles and its severe complications, with a recommended two-dose series of the MMR vaccine administered during infancy and early childhood. The vaccine is safe, effective, and vital for safeguarding community health.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Molecular Randomness Influences Variations in Aging and Lifespan
New research reveals that randomness at the molecular and cellular levels significantly influences individual aging and lifespan, offering fresh insights into the biology of aging and potential personalized therapies.
Innovative 'Smart Insulin' Offers Promise in Minimizing Hypoglycemia Episodes
Discover how Indiana University scientists have engineered a new 'smart insulin' protein that mimics natural hormonal responses, offering hope for better blood sugar management and reduced hypoglycemia in type 1 diabetes patients.
New Non-Opioid Painkiller Shows Promise in Outperforming Traditional Opioids
A groundbreaking non-opioid drug developed at Duke University shows potential to provide powerful pain relief without the addictive side effects associated with traditional opioids. Preclinical studies reveal SBI-810's promising performance in managing acute and chronic pain safely.



